Jonathan H. Kaufman 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Purchase |
2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 212,294 16.200% |
11,250 (+5.60%) |
Filing |
| 2024-05-06 4:05 pm Sale |
2024-05-02 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 201,044 19.300% |
-3,333 (-1.63%) |
Filing |
| 2024-03-19 4:10 pm Purchase |
2024-03-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 204,377 21.000% |
16,875 (+9.00%) |
Filing |
| 2024-03-15 12:13 pm Purchase |
2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 187,502 19.500% |
18,113 (+10.69%) |
Filing |
| 2024-03-06 5:05 pm Purchase |
2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 169,389 18.300% |
10,833 (+6.83%) |
Filing |
| 2023-06-21 5:05 pm Purchase |
2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Jonathan H. Kaufman | 158,555 20.100% |
158,555 (New Position) |
Filing |